| GC33795-10mM(1mLinDMSO) |
|
116183-66-5 |
|
0 |
C28H32O16 |
|
|
|
| GC33793-10mg |
|
85916-47-8 |
|
0 |
C97H154N34O36S2 |
|
|
|
| GC33793-5mg |
|
85916-47-8 |
|
0 |
C97H154N34O36S2 |
|
|
|
| GC33793-1mg |
|
85916-47-8 |
|
0 |
C97H154N34O36S2 |
|
|
|
| GC33793-500μg |
|
85916-47-8 |
|
0 |
C97H154N34O36S2 |
|
|
|
| GC33791-5mg |
|
20958-15-0 |
|
0 |
C19H18O3 |
|
|
|
| GC33790-25mg |
|
8 |
Adrenocorticotropic Hormone (ACTH) (4-10), human
|
0 |
C44H59N13O10S |
|
|
|
| GC33790-10mg |
|
8 |
Adrenocorticotropic Hormone (ACTH) (4-10), human
|
0 |
C44H59N13O10S |
|
|
|
| GC33790-5mg |
|
8 |
Adrenocorticotropic Hormone (ACTH) (4-10), human
|
0 |
C44H59N13O10S |
|
|
|
| GC33789-100mg |
|
1069-79-0 |
1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (1,2-DSPE)
|
0 |
C41H82NO8P |
|
|
|
| GC33789-10mM(1mLinDMSO) |
|
1069-79-0 |
1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (1,2-DSPE)
|
0 |
C41H82NO8P |
|
|
|
| GC33788-5mg |
|
53917-42-3 |
Adrenocorticotropic Hormone (ACTH) (18-39), human (CLIP (human))
|
0 |
C112H165N27O36 |
|
|
|
| GC33788-1mg |
|
53917-42-3 |
Adrenocorticotropic Hormone (ACTH) (18-39), human (CLIP (human))
|
0 |
C112H165N27O36 |
|
|
|
| GC33787-25mg |
|
91183-98-1 |
UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt)
|
0 |
C17H25N3Na2O17P2 |
|
|
|
| GC33787-10mg |
|
91183-98-1 |
UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt)
|
0 |
C17H25N3Na2O17P2 |
|
|
|
| GC33787-5mg |
|
91183-98-1 |
UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt)
|
0 |
C17H25N3Na2O17P2 |
|
|
|
| GC33785-5mg |
|
90419-12-8 |
Pancreatic Polypeptide, rat (Rat pancreatic polypeptide)
|
0 |
C195H298N58O57S |
|
|
|
| GC33785-1mg |
|
90419-12-8 |
Pancreatic Polypeptide, rat (Rat pancreatic polypeptide)
|
0 |
C195H298N58O57S |
|
|
|
| GC33785-500μg |
|
90419-12-8 |
Pancreatic Polypeptide, rat (Rat pancreatic polypeptide)
|
0 |
C195H298N58O57S |
|
|
|
| GC33784-25mg |
|
102029-74-3 |
β-Casomorphin, human (Human β-casomorphin 7)
|
0 |
C44H61N7O11 |
|
|
|
